The op-ed by Ara Darzi on November 7 highlighted a critical issue of antibiotic resistance. Darzi stressed the dangers posed by bacteria that are becoming impervious to many commonly used antibiotics. This growing threat, if not addressed, could severely limit several medical procedures.
Bacterial infections that are resistant to antibiotics may impede surgeries, joint replacements, and transplantations. Additionally, cancer treatments that rely on chemotherapy could be compromised. The situation calls for immediate and decisive action.
The photograph shows machinery used for producing amoxicillin at a Sandoz facility in Kundl, Austria. The image serves as a reminder of the importance of manufacturing effective antibiotics to combat resistant bacteria.
